JACOBS LEVY EQUITY MANAGEMENT, INC
Position in AKBA — Akebia Therapeutics, Inc.
CIK 884414
FLORHAM PARK, NJ
Position in AKBA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,871,249
+$4,274,010 QoQ
Shares Held
4,273,026
+894.5% QoQ
Ownership
1.54%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#6
of 170 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 87%
Shared 0%
None 13%
Common Shares in AKBA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026JACOBS LEVY EQUITY MANAGEMENT, INC holds $311,064,443 across 17 Drug Manufacturers - Specialty & Generic names. AKBA ranks #8 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
726,112 | $122,378,916 | |
| 2 | LNTH |
Lantheus Holdings, Inc.
|
699,583 | $77,611,738 | |
| 3 | ZTS |
Zoetis Inc.
|
579,079 | $41,612,616 | |
| 4 | LQDA |
Liquidia Corp
|
240,752 | $19,195,156 | |
| 5 | IRWD |
Ironwood Pharmaceuticals Inc
|
4,065,964 | $17,117,708 | |
| 6 | BIOA |
BioAge Labs, Inc.
|
377,085 | $9,242,353 | |
| 7 | PCRX |
Pacira BioSciences, Inc.
|
199,800 | $5,068,926 | |
| 8 | AKBA |
Akebia Therapeutics, Inc.
This page
|
4,273,026 | $4,871,249 |
All Filings in AKBA
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,871,249 | 4,273,026 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $597,239 | 429,669 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,059,077 | 657,812 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,808,706 | 662,530 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $4,386,665 | 1,205,128 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $3,032,361 | 1,579,355 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $2,334,549 | 1,228,710 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,685,103 | 2,034,169 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $2,136,627 | 2,094,733 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $2,996,767 | 1,637,578 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $2,302,587 | 1,856,925 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,959,729 | 1,719,061 | Shares | Sole | 2023-11-17 | |
| 2023-06-30 | $1,231,619 | 1,346,032 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $671,285 | 1,198,724 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,162,520 | 2,014,767 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $645,529 | 2,042,816 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $274,498 | 777,617 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $707,044 | 984,741 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $6,187,654 | 2,737,900 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $7,666,689 | 2,662,045 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $11,018,795 | 2,907,334 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $9,031,278 | 2,668,029 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $5,585,585 | 1,994,852 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,751,741 | 697,905 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $6,343,801 | 467,143 | Shares | Sole | 2020-08-17 | |
| 2020-03-31 | $3,773,005 | 497,758 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||